Alison Gartland

Professor Alison Gartland from the University of Sheffield's School of Medicine and Population Health is a leading researcher in bone and cancer biology. Her work focuses on P2 receptor signaling in musculoskeletal disease and cancer metastasis, particularly examining ATP-mediated communication between bone cells and tumors.

• Founded the UK Purine Club
• Member of four major bone research societies
• Chair of Medical School Graduate Research Committee

Her research explores:

• Mechanisms of bone metastasis in prostate and breast cancers
• Effects of metal ions from prosthetics on bone cells
• Purinergic receptor polymorphisms in skeletal health
• Development of novel therapeutic targets for sarcomas

Key publication trends show expertise in:

• Bone-cancer signaling pathways
• Genetic factors affecting bone density
• Receptor isoforms in metastatic processes

She supervises postgraduate student Luke Tattersall and collaborates with Professor Mark Wilkinson, Dr Dawn Teare, and other researchers across multidisciplinary projects.